At Yahoo Business News.
++++++++++
QLT Phototherapeutics Inc. (QLTI) 36 3/16 +1 11/16: ING Barings upgrades biotech firm from "buy" to "strong buy" as they see Visudyne on the market by as soon as year-end; recent price weakness creates buying opportunity.....
--------------
QLT Photother. QLTI Warburg Dillon Read from Buy to Strong Buy
_____________________ and today's headlines ______________
NEWS
11/10 11:22 QLT Photo. Maintained `Speculative Buy' at Nesbitt Burns
11/10 11:12 QLT Phototherapeutics Maintained `Strong Buy' at CIBC
11/10 10:26 QLT Phototherapeut. Reiterated `Strong Buy' at Adams, Harkness
11/10 10:16 QLT Photo Reiterated `Strong Buy' at Deutsche Bank AB
11/10 9:59 QLT Phototherapeutics Maintained `Hold' at TD Securities
11/10 9:22 QLT Phototherapeutics Raised to `Outperform' at RBC Dominion
11/10 8:55 QLT Phototherapeutics Raised to `Strong Buy' at ING Barings
11/10 7:47 QLT Phototherap. Raised to `Strong Buy' at Warburg Dillon
++++++++++++=
Princeton, New Jersey, Nov. 10 (Bloomberg Data) -- QLTt Phototherapeutics
Inc. (QLTI US) was raised to ``strong buy' from ``buy' by analyst Joseph P.
Dougherty at Warburg Dillon Read Inc. The 12-month target price is $55.00 per
share.
++++++++++++++
Princeton, New Jersey, Nov. 10 (Bloomberg Data) -- QLT Phototherapeutics
Inc. (QLTI US) was raised to ``strong buy' from ``buy' by analyst Paul E.
Kelly at ING Barings.
+++++++++++++++
Toronto, Nov. 10 (Bloomberg Data) -- QLT Phototherapeutics Inc. (QLT CN)
was raised to ``outperform' from ``neutral' by analyst Douglas Miehm at RBC
Dominion Securities. The 12-month target price is C$61.50 per share.
++++++++++++
Toronto, Nov. 10 (Bloomberg Data) -- QLT Phototherapeutics Inc. (QLT CN)
was maintained ``hold' by analyst Hari Sambasivam at TD Securities.
The 12-month target price is C$48.50 per share.
++++++++++
Princeton, New Jersey, Nov. 10 (Bloomberg Data) -- QLT Phototherapeutics
Inc. (QLTI US) was reiterated ``strong buy' by analyst Kevin C. Tang at
Deutsche Banc Alex. Brown.
+++++++++++
Princeton, New Jersey, Nov. 10 (Bloomberg Data) -- QLT Phototherapeutics
Inc. (QLTI US) was reiterated ``strong buy' by analyst Carol Werther at
Adams, Harkness & Hill. The 12-month target price is $59.00 per share.
++++++++++++++++++
Toronto, Nov. 10 (Bloomberg Data) -- QLT Phototherapeutics Inc. (QLT CN)
was maintained ``strong buy' by analyst Lennox Gibbs at CIBC World Markets
Inc.. The 12-month target price is C$79.00 per share.
+++++++++++++++++
Toronto, Nov. 10 (Bloomberg Data) -- QLT Phototherapeutics Inc. (QLT CN)
was maintained ``speculative buy' by analyst Christine Charette at Nesbitt
Burns. The 12-month target price is C$87.50 per share. |
